Dr
Anbazhagan
S
Dr
Anbazhagan
S
Scientist B
ICMR-National Animal Resource Facility for Biomedical Research
Biography
Dr. Anbazhagan completed his undergraduate studies at TANUVAS, Tamil Nadu, and obtained his postgraduate degree from ICAR-IVRI, Uttar Pradesh. He has carried out his doctoral research in the field of veterinary microbiology at ICAR-IVRI, U.P. During his research period, he obtained expertise in working with risk group 2 and 3-level zoonotic pathogens. He had experience in the development of genome-edited vaccines for BSL3 bacterial pathogens. He has conducted numerous small and large animal experiments for newly developing vaccine candidates for zoonotic and veterinary pathogens such as Brucella sp., Clostridium sp., Leptospira sp., Rabies and Bluetongue virus. Dr. Anbazhagan S is proficient in working with next-generation sequencing data for microbial genomic characterization. His endeavors also involved the isolation, characterization, and analysis of antimicrobial resistance in various bacterial pathogens. Additionally, he conducted molecular docking studies for SARS-CoV-2, identifying therapeutic molecules and exploring the interaction of SARS-CoV-2 with ACE2 receptors in domestic and wild animals. His multidisciplinary approach displays a comprehensive understanding of veterinary microbiology and one health, contributing significantly to the understanding and development of strategies against infectious agents. Research interests
1. Development of genetically modified vaccine for zoonotic pathogens.
2. Handling (culture and identification) of zoonotic bacterial pathogens
2. Conducting preclinical vaccine trials in different animal models.
3. Microbial genomic analysis of bacterial pathogens. Projects you're working on
Preclinical Evaluation of Animal and Human vaccines
Health monitoring of small and large laboratory animals Discipline
Bacteriology Molecular biology Virology Host species
Cattle Dogs Horses Pigs Small ruminants Zoonoses Pathogen
Bacteria Bacteria›Brucella Bacteria›Leptospira Bacteria›Mycobacteria bovis Bacteria›Salmonella Viruses Stage of vaccine development
Pre-clinical trials